Cytovale Names Dave Vort Chief Commercial Officer [Yahoo! Finance]
iRhythm Technologies, Inc. (IRTC)
Last irhythm technologies, inc. earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.irhythmtech.com
Company Research
Source: Yahoo! Finance
Proven Medical Device Executive Joins Cytovale to Drive Commercial Growth of the Company's IntelliSep ® Rapid Sepsis Detection Technology SAN FRANCISCO Feb. 4, 2025 /PRNewswire/ -- Cytovale ® , a commercial-stage medical diagnostics company, today announced the appointment of Dave Vort as its new chief commercial officer. With more than 25 years of experience in the medical device sector, he will lead commercialization and market expansion as the company addresses dramatically growing demand for its artificial intelligence (AI)-enabled U.S. Food and Drug Administration (FDA)-cleared rapid sepsis detection solution IntelliSep ® Cytovale (PRNewsfoto/Cytovale) "With our latest $100 million funding and strong interest in IntelliSep, Cytovale is solidifying its position as a leader in providing hospitals with essential tools to swiftly address and treat the life-threatening condition of sepsis," said Ajay Shah , Cytovale co-founder and CEO. "Expanding our team with top-tier expertis
Show less
Read more
Impact Snapshot
Event Time:
IRTC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRTC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRTC alerts
High impacting iRhythm Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
IRTC
News
- HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
- Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law FirmGlobeNewswire
- iRhythm Technologies (NASDAQ:IRTC) had its price target raised by analysts at Morgan Stanley from $195.00 to $205.00. They now have an "overweight" rating on the stock.MarketBeat
- HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
- New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian PopulationGlobeNewswire
IRTC
Earnings
- 10/30/25 - Beat
IRTC
Sec Filings
- 12/3/25 - Form 4
- 12/3/25 - Form 4
- 12/2/25 - Form 4
- IRTC's page on the SEC website